These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Serum brain-derived neurotrophic factor levels as a predictor for Alzheimer disease progression. Tsai MJ; Lin YS; Chen CY; Lee WJ; Fuh JL J Chin Med Assoc; 2023 Nov; 86(11):960-965. PubMed ID: 37713318 [TBL] [Abstract][Full Text] [Related]
25. Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis. Du Y; Wu HT; Qin XY; Cao C; Liu Y; Cao ZZ; Cheng Y J Mol Neurosci; 2018 Jul; 65(3):289-300. PubMed ID: 29956088 [TBL] [Abstract][Full Text] [Related]
26. Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease. Liu YH; Jiao SS; Wang YR; Bu XL; Yao XQ; Xiang Y; Wang QH; Wang L; Deng J; Li J; Zhou XF; Zhou HD; Wang YJ Mol Neurobiol; 2015; 51(3):1271-7. PubMed ID: 24986007 [TBL] [Abstract][Full Text] [Related]
27. BDNF serum concentrations show no relationship with diagnostic group or medication status in neurodegenerative disease. Woolley JD; Strobl EV; Shelly WB; Karydas AM; Robin Ketelle RN; Wolkowitz OM; Miller BL; Rankin KP Curr Alzheimer Res; 2012 Sep; 9(7):815-21. PubMed ID: 21605064 [TBL] [Abstract][Full Text] [Related]
28. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets. Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL; Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169 [TBL] [Abstract][Full Text] [Related]
29. DNA methyltransferase 3, a target of microRNA-29c, contributes to neuronal proliferation by regulating the expression of brain-derived neurotrophic factor. Yang G; Song Y; Zhou X; Deng Y; Liu T; Weng G; Yu D; Pan S Mol Med Rep; 2015 Jul; 12(1):1435-42. PubMed ID: 25815896 [TBL] [Abstract][Full Text] [Related]
31. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
32. Cognitive impairment and BDNF serum levels. Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039 [TBL] [Abstract][Full Text] [Related]
33. Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's disease. Chatterjee M; Del Campo M; Morrema THJ; de Waal M; van der Flier WM; Hoozemans JJM; Teunissen CE Alzheimers Res Ther; 2018 Jun; 10(1):52. PubMed ID: 29859129 [TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease. Counts SE; He B; Prout JG; Michalski B; Farotti L; Fahnestock M; Mufson EJ Curr Alzheimer Res; 2016; 13(7):800-8. PubMed ID: 26825093 [TBL] [Abstract][Full Text] [Related]
35. Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia. Konukoglu D; Andican G; Fırtına S; Erkol G; Kurt A Acta Neurol Belg; 2012 Sep; 112(3):255-60. PubMed ID: 22740022 [TBL] [Abstract][Full Text] [Related]
36. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease. Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636 [TBL] [Abstract][Full Text] [Related]
37. Toxic Amyloid-β42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage. Futamura A; Hieda S; Mori Y; Kasuga K; Sugimoto A; Kasai H; Kuroda T; Yano S; Tsuji M; Ikeuchi T; Irie K; Ono K J Alzheimers Dis; 2021; 80(2):639-646. PubMed ID: 33579852 [TBL] [Abstract][Full Text] [Related]
38. Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease. Leyhe T; Eschweiler GW; Stransky E; Gasser T; Annas P; Basun H; Laske C J Alzheimers Dis; 2009; 16(3):649-56. PubMed ID: 19276559 [TBL] [Abstract][Full Text] [Related]
39. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease. Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653 [TBL] [Abstract][Full Text] [Related]
40. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. Weinstein G; Beiser AS; Choi SH; Preis SR; Chen TC; Vorgas D; Au R; Pikula A; Wolf PA; DeStefano AL; Vasan RS; Seshadri S JAMA Neurol; 2014 Jan; 71(1):55-61. PubMed ID: 24276217 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]